Therefore, these results demonstrate that EGFR mutant proteins, not the wild‐type form, regulate SREBP1 and FASN expression in Gefitinib‐resistant H1975 NSCLC cells. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.